Multiple estrogen function in human prostate cancer cells

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 70-84

  Carruba, Giuseppe ^a   Miceli, Maria D ^a   Comito, Loredana ^a   Farruggio, Rosaria ^b   Sorci, Carmela M G ^a   Oliveri, Giuseppa ^b   Amodio, Rosalba ^a   Di Falco, Marco ^a   D'Amico, Domenico ^a   Castagnetta, Luigi A M ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ospedale Oncologico M Ascoli   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CELL DNA; CELL NUCLEUS RECEPTOR; DIETHYLSTILBESTROL; ESTROGEN; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN; HORMONE DERIVATIVE; PROGESTERONE RECEPTOR; SEX HORMONE;

CANCER CELL; CANCER GROWTH; CAUSE OF DEATH; CELL NUCLEUS; CONFERENCE PAPER; CYTOTOXICITY; DNA CONTENT; DNA SYNTHESIS; HUMAN; IMMUNOCYTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; ORCHIECTOMY; PROSTATE CANCER; RECEPTOR BINDING;

EID: 0029884121     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16229.x     Document Type: Conference Paper

References (48)

1. CARTER, H. B. & D. S. COFFEY. 1990. The prostate: an increasing medical problem. Prostate 16: 39-48.
2. BERRY, S. J. & J. T. ISAACS. 1984. Comparative aspects of prostatic growth and androgen metabolism with aging in the rat versus the dog. Endocrinology 114: 511-520.
3. IMPERATO-MCGINLEY, J. 1984. 5α-Reductase deficiency in man. Prog. Cancer Res. Ther. 31: 491-504.
4. TURKES, A. O., W. B. PEELING, D. W. WILSON & K. GRIFFITHS. 1988. Evaluation of different endocrine approaches in the treatment of prostatic carcinoma. In New Developments in Biosciences 4. Endocrine Management of Prostatic Carcinoma. H. Klosterhalfen, Ed.: 75-86. de Gruyter. Berlin.
5. FERRO, M. A. 1991. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation. Urol. Clin. North Am. 18: 139-143.
6. VAN AUBEL, O. G. J. M., J. BOLT-DE VRIES, M. A. BLANKENSTEIN, F. J. TEN KATE & F. H. SCHRÖDER. 1985. Nuclear androgen receptor content in biopsy specimens from histologically normal, hyperplastic, and cancerous human prostatic tissue. Prostate 6: 185-194.
7. BOWMAN, S. P., D. M. BARNES, N. J. BLACKLOCK & P. J. SULLIVAN. 1986. Regional variation of cytosol androgen receptors throughout the diseased human prostate gland. Prostate 8: 167-180.
8. CASTAGNETTA, L., G. CARRUBA, M. CALABRÒ, L. POLITO, L. BLASI & M. PAVONE-MACALUSO. 1991. Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy. Urol. Res. 19: 337-341.
9. CASTAGNETTA, L., G. CARRUBA, E. FECAROTTA, M. LO CASTO, R. CUSIMANO & M. PAVONE-MACALUSO. 1992. Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate. Urol. Res. 20: 127-132.
10. MURPHY, J. B., R. C. EMMOTT, L. L. HICKS & P. C. WALSH. 1980. Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin: a marker for estrogen-responsive tissues? J. Clin. Endocrinol. Metab. 50: 938-947.
11. EKMAN, P., E. R. BARRACK, G. L. GREENE, E. V. JENSEN & P. C. WALSH. 1983. Estrogen receptors in human prostate: evidence for multiple binding sites. J. Clin. Endocrinol. Metab. 57: 166-176.
12. CHAISIRI, N. & C. G. PIERREPOINT. 1980. Examination of the distribution of oestrogen receptor between stromal and epithelial compartments of the canine prostate. Prostate 1: 357-366.
13. SONNENSCHEIN, C., N. OLEA, M. E. PASANEN & A. M. SOTO. 1989. Negative control of cell proliferation: human prostate cancer cells and androgens. Cancer Res. 49: 3474-3481.
14. IGUCHI, T., Y. FUKAZAWA, N. TANI, T. SATO, S. OZAWA, N. TAKASUGI, T. SHUIN, Y. KUBOTAL & V. PETROV. 1990. Effect of some hormonally active steroids upon the growth of LNCaP human prostate tumor cells in vitro. Cancer J. 3: 184-191.
15. CASTAGNETTA, L., O. M. GRANATA, L. POLITO, L. BLASI, S. CANNELLA & G. CARRUBA. 1994. Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and response of human prostate cancer cells. J. Steroid Biochem. 49: 351-357.
16. CASTAGNETTA, L., M. D. MICELI, M. G. SORCI, U. PFEFFER, R. FARRUGGIO, G. OLIVERI, M. CALABRÒ & G. CARRUBA. 1995. Growth of LNCaP cells is stimulated by estradiol via its own receptor. Endocrinology 136: 2309-2319.
17. CASTAGNETTA, L., M. LO CASTO, T. MERCADANTE, L. POLITO, S. COWAN & R. E. LEAKE. 1983. Intra-tumoural variation of oestrogen receptor status in endometrial cancer. Br. J. Cancer 47: 261-267.
18. CARRUBA, G., U. PFEFFER, E. FECAROTTA, D. A. COVIELLO, E. D'AMATO, M. LO CASTO, G. VIDALI & L. CASTAGNETTA. 1994. Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res. 54: 1190-1193.
19. CASTAGNETTA, L., M. LO CASTO, O. M. GRANATA, M. CALABRÒ, M. CIACCIO & R. E. LEAKE. 1987. Soluble and nuclear oestrogen receptor status of advanced endometrial cancer in relation to subsequent clinical prognosis. Br. J. Cancer 55: 543-546.
20. CASTAGNETTA, L., A. TRAINA, G. CARRUBA, E. FECAROTTA, G. PALAZZOTTO & R. E. LEAKE. 1992. The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes. Br. J. Cancer 65: 167-170.
21. CIOCCA, D. R. & E. H LUQUE. 1991. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen-receptor associated protein in breast and endometrial cancer. Breast Cancer Res. Treat. 20: 33-42.
22. FAUCHER, C., J. CAPDEVIELLE, I. CANAL, P. FERRARA, H. MAZARGUIL, W. L. MCGUIRE & J. M. DARBON. 1993. The 28-kDa protein whose phosphorylation is induced by protein kinase C activators in MCF-7 cells belongs to the family of low molecular mass heat shock proteins and is the estrogen-regulated 24-kDa protein. J. Biol. Chem. 268: 15168-15173.
23. KING, R. J. B., J. R. FINLAY, A. E. COFFER, R. MILLIS & R. D. RUBENS. 1987. Characterization and biological relevance of a 29-kDa estrogen-related protein. J. Steroid Biochem. 27: 471-475.
24. CAMPISI, D., M. CUTOLO, G. CARRUBA et al. 1993. Evidence for soluble and nuclear site I binding of estrogens in human aorta. Atherosclerosis 103: 267-277.
25. CASTAGNETTA, L. & G. CARRUBA. 1995. Human prostate cancer: a direct role for estrogens. In Non-Reproductive Actions of Sex Steroids. Ciba Foundation Symposium No. 191. J. Goode, Ed.: 269-289. Wiley. New York.
26. HUGGINS, C. & C. V. HODGES. 1941. Studies on prostatic cancer. I. The effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1: 293-297.
27. HUGGINS, C., R. E. STEVENS & C. V. HODGES. 1941. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg. 43: 209-223.
28. BERNS, E. M. J. J., W. DE BOER & E. MULDER. 1986. Androgen-dependent growth regulation and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9: 247-259.
29. SCHUURMANS, A. L. G., J. BOLT & E. MULDER. 1988. Androgens stimulate both growth-rate and epidermal growth factor receptor activity of the human prostate tumor cell line LNCaP. Prostate 12: 55-64.
30. WOLF, D. A., P. SCHULZ & F. FITTLER. 1991. Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP. Br. J. Cancer 64: 47-53.
31. CARRUBA, G., R. E. LEAKE, F. RINALDI, D. CHALMERS, L. COMITO, C. SORCI, M. PAVONE-MACALUSO & L. CASTAGNETTA. 1994. Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59: 412-420.
32. VAN STEENBRUGGE, G. J., C. J. C. VAN UFFELEN, J. BOLT & F. H. SCHRÖDER. 1991. The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity. J. Steroid Biochem. Mol. Biol. 40: 207-214.
33. KIRSCHENBAUM, A., M. REN & A. C. LEVINE. 1993. Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line. Steroids 58: 439-444.
34. LANGELER, E. G., C. J. C. VAN UFFELEN, M. A. BLANKENSTEIN, G. J. VAN STEENBRUGGE & E. MULDER. 1993. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP. Prostate 23: 213-223.
35. HASENSON, M., B. ARTLEY-ASP, C. KIHLFORS, A. LUNDEN, J. A. GUSTAFSSON & A. POUSETTE. 1991. Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r. Prostate 17: 183-194.
36. LEAV, I., F. B. MERK, P. OFNER, G. GOODRICH, P. W-L. KWAN, B. M. STEIN, M. SAR & W. E. STUMPF. 1978. Bipotentiality of response to sex hormones by the prostate of castrated or hypophysectomized dogs: direct effects of estrogen. Am. J. Pathol. 93: 69-92.
37. SCHULZE, H. & E. R. BARRACK. 1987. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia. Prostate 11: 145-162.
38. SWANECK, G. E., J. M. ALVAREZ & G. SUFRIN. 1982. Multiple species of estrogen binding sites in the nuclear fraction of the rat prostate. Biochem. Biophys. Res. Commun. 106: 1441-1447.
39. MOBBS, B. G. & I. E. JOHNSON. 1986. Quantitative relationships between cytosol and nuclear estrogen and progesterone receptors in the R3327 prostate adenocarcinoma of rats treated with diethylstilbestrol. Prostate 8: 256-264.
40. DONNELLY, B. J., W. H. LAKEY & W. A. MCBLAIN. 1983. Estrogen receptors in human benign prostatic hyperplasia. J. Urol. 130: 183-187.
41. BERN, H. A. 1963. Epithelial metaplasia in the prostate and other genital structures of male mammals. Natl. Cancer Inst. Monogr. 12: 43-45.
42. WILSON, J. D. 1980. The pathogenesis of benign prostatic hyperplasia. Am. J. Med. 68: 745-747.
43. WILDING, G. 1992. The importance of steroid hormones in prostate cancer. Cancer Surv. 14: 113-130.
44. LEAV, I., F. B. MERK, P. W-L. KWAN & S-M. HO. 1989. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 15: 23-40.
45. EATON, C. L. & C. G. PIERREPOINT. 1982. Epithelial and fibroblastoid cell lines derived from the normal canine prostate. II. Cell proliferation in response to steroid hormones. Prostate 3: 493-506.
46. SCHUURMANS, A. L. G., J. BOLT, M. M. VOORHORST, M. A. BLANKENSTEIN & E. MULDER. 1988. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids. Int. J. Cancer 42: 917-922.
47. IWAMURA, M., P. M. SLUSS, J. B. CASAMENTO & A. T. COCKETT. 1993. Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 22: 243-252.
48. CARRUBA, G., M. D. MICELI, D. D'AMICO, R. FARRUGGIO, L. COMITO, A. MONTESANTI, L. POLITO & L. CASTAGNETTA. 1995. Sex steroids up-regulate E-cadherin expression in hormone-responsive LNCaP human prostate cancer cells. Biochem. Biophys. Res. Commun. 212: 624-631.